Analyzing the risk of osteoporosis and fracture in rheumatoid arthritis patients who have been treated with various biologics
ConclusionThe treatment option has emerged as a critical determinant in the context of future osteoporosis and osteoporotic fracture risks among RA. These findings offer a valuable resource for clinicians, empowering them to tailor bespoke treatment strategies for RA patients, thereby mitigating the potential for future osteoporosis and fractures.
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Yu ‐Jih Su,
Chun‐Yu Lin,
Chung‐Yuan Hsu Tags: ORIGINAL ARTICLE Source Type: research
More News: Abatacept | Arthritis | Databases & Libraries | Orencia | Orthopaedics | Osteoporosis | Rheumatoid Arthritis | Rheumatology | Rituxan